Sevelamer arsenite nanoparticle as a Pi-responsive drug carrier and embolic agent for chemoembolization

Arsenic trioxide (As(2)O(3), ATO) has limited therapeutic benefit to treat solid tumors, whether used alone or in combination. Nanoscale drug delivery vehicles have great potential to overcome the limitation of the utility of ATO by rapid renal clearance and dose-limiting toxicity. Polymeric materia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Qiu-Chen, Tang, Jian-Jun, Zhao, Jun, Lv, Yang-Feng, Deng, Zhi-Qiang, Chen, Hong, Xu, Yu-Hua, Xie, Chuan-Sheng, Liang, Qing-Rong, Luo, Rong-Guang, Tang, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103487/
https://www.ncbi.nlm.nih.gov/pubmed/35532152
http://dx.doi.org/10.1080/10717544.2022.2072541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103487/
https://www.ncbi.nlm.nih.gov/pubmed/35532152
http://dx.doi.org/10.1080/10717544.2022.2072541

Ejemplares similares